Shilpa Medicare secures Europe approval for smoking cessation drug Varenicline
Varenicline is indicated for smoking cessation in adults. It is used for quitting smoking.
Karnataka: Shilpa Medicare Limited has announced that the Company has received closure of Decentralized Procedure for Varenicline Tablets, 0.5 mg and 1 mg.Commercial supplies shall be started after the approval of National Procedure. Varenicline is indicated for smoking cessation in adults. It is used for quitting smoking. This product had sales of about 57 Million USD as of December 2021...
Karnataka: Shilpa Medicare Limited has announced that the Company has received closure of Decentralized Procedure for Varenicline Tablets, 0.5 mg and 1 mg.
Shilpa Medicare Limited started its operations as an API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of API and Formulation globally in different regulated markets.
Read also: Shilpa Medicare gets Code J for Pemetrexed Injection
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd